Condition: Knee Cartilage Lesion · Sponsor: Cartilage Repair Systems BV
CartiONE is a technique used in autologous articular-chondrocyte-based treatments for symptomatic focal articular-cartilage lesions of the knee. The CartiONE technique was evaluated in combination with an osteochondrally placed, biodegradable, biocompatible, load-bearing copolymer (PolyActive) scaffold in the INSTRUCT trial (NCT01041885). To evaluate the clinical effectiveness of the CartiONE technique and confirm its safety, in this study retrospective baseline data and follow-up data, documented as per the standard of care at the participating hospitals, will be collected for patients who were treated with CartiONE. The potential number of patients in this study is 122 and involves patients treated with CartiONE from 2010 to 2023 with a minimum follow-up period of six months, spread across five countries: Belgium, England, Greece, Poland, and Austria.
This description comes directly from the study's public registry record.
Nele Vanparys · +34665245704 · nvanparys@orteq.com
Always discuss trial participation with your own doctor first.
| UZ Ghent | Ghent, Oost-Vlaanderen, Belgium | Recruiting |
| AZ Monica | Antwerp, Belgium | Recruiting |
| MIRAI | Warsaw, Poland | Not Yet Recruiting |
| University Hospitals Coventry & Warwickshire NHS Trust | Coventry, United Kingdom | Not Yet Recruiting |
| Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Foundation Trust | Oswestry, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06809231